BIO KEY INTERNATIONAL INC (BKYI)

Every figure this model derived for BKYI, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 5,964 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 1,379,300 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 3,806,635 AssetsCurrent 2026-06-30
current liabilities 3,013,184 LiabilitiesCurrent 2026-06-30
equity 4,334,878 StockholdersEquity 2026-06-30
interest expense 60,483 InterestPaidNet 2026-06-30
ocf -4,157,115 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 6,699,013 RevenueFromContractWithCustomerIncludingAssessedTax 2026-06-30
sbc 175,646 AllocatedShareBasedCompensationExpense 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up BKYI on one particular measure came for.

RatioValue
cash operating margin-82.71
current ratio1.61
current ratio reported1.26
deferred revenue growth-25.17
dilution pct223.0
fcf margin-62.14
growth cv1.7
interest cover-95.73
operating margin-86.43
owner earnings margin-64.77
revenue growth-3.07
revenue growth per share-69.99
roic-154.77
rule of 40-89.5
sbc pct revenue2.62

What to be careful about

What this model itself distrusts about BKYI's figures. Written by the derivation as it ran, not added afterwards.